Block Drug OTC Small Packaging Denial Mishandled By FDA, CHPA Says
This article was originally published in The Rose Sheet
Executive Summary
FDA mishandled its decision to deny Block Drug a small packaging exemption by assuming off-label information could not be easily read and interpreted by consumers, the Consumer Healthcare Product Association maintains in Oct. 3 comments to the agency.